Stockscreener 앱 받기
32.68
4.30%
-1.47
시간 외 거래:
32.60
-0.08
-0.24%
전일 마감가:
$34.15
열려 있는:
$33.89
하루 거래량:
697.40K
Relative Volume:
0.49
시가총액:
$2.57B
수익:
$399.58M
순이익/손실:
$-54.04M
주가수익비율:
-43.57
EPS:
-0.75
순현금흐름:
$40.13M
1주 성능:
+2.67%
1개월 성능:
+5.42%
6개월 성능:
-1.45%
1년 성능:
-3.11%
1일 변동 폭
$32.34
$34.14
1주일 범위
$32.09
$34.89
52주 변동 폭
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
명칭
Veracyte Inc
전화
(650) 243-6300
주소
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
VCYT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
32.68 | 2.69B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
468.00 | 177.38B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
185.91 | 135.85B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
627.17 | 51.87B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.38 | 35.70B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.24 | 31.70B | 15.70B | 1.24B | 2.01B | 6.91 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-20 | 개시 | Craig Hallum | Buy |
| 2024-12-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-10-16 | 개시 | UBS | Buy |
| 2024-10-10 | 개시 | Guggenheim | Buy |
| 2024-02-23 | 재확인 | Needham | Buy |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-11-18 | 재개 | Goldman | Buy |
| 2021-06-15 | 개시 | Raymond James | Outperform |
| 2021-02-18 | 재개 | Needham | Buy |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 개시 | Morgan Stanley | Underweight |
| 2019-07-31 | 개시 | Lake Street | Buy |
| 2019-07-02 | 개시 | Needham | Buy |
| 2018-11-29 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-10-31 | 업그레이드 | Janney | Neutral → Buy |
| 2017-11-07 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-11-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 재개 | BTIG Research | Buy |
| 2016-11-14 | 재개 | Leerink Partners | Outperform |
| 2015-12-18 | 개시 | Cantor Fitzgerald | Buy |
| 2015-06-11 | 재확인 | Leerink Partners | Outperform |
| 2013-11-26 | 개시 | William Blair | Outperform |
모두보기
Veracyte Inc 주식(VCYT)의 최신 뉴스
Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025 - BioSpace
Veracyte to present first prospective data on hormone therapy biomarker By Investing.com - Investing.com South Africa
Veracyte, Inc. Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented At Astro 2025 - MarketScreener
First-Ever Hormone Therapy Response Predictor: Veracyte's Groundbreaking Prostate Cancer Study at ASTRO 2025 - Stock Titan
Strs Ohio Makes New Investment in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (NASDAQ:VCYT) SVP Annie Mcguire Sells 2,283 Shares - MarketBeat
Exchange Traded Concepts LLC Purchases 23,047 Shares of Veracyte, Inc. $VCYT - MarketBeat
Assenagon Asset Management S.A. Increases Stake in Veracyte, Inc. $VCYT - MarketBeat
Price Action: Can 374Water Inc be recession proofMarket Activity Report & Safe Entry Momentum Stock Tips - خودرو بانک
Short Covering: What is the dividend yield of Veracyte IncTrade Entry Report & Smart Investment Allocation Insights - خودرو بانک
Market Rankings: What is the Moat Score of AMN Healthcare Services IncSwing Trade & Daily Technical Forecast Reports - خودرو بانک
Market Trends: Is Veracyte Incs ROIC above industry averageEarnings Recap Summary & Free Real-Time Volume Trigger Notifications - خودرو بانک
Aug Intraday: Is Veracyte Inc a strong candidate for buy and holdJuly 2025 Closing Moves & Stepwise Swing Trade Plans - خودرو بانک
Is Veracyte Inc. trending in predictive chart modelsJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Can momentum traders help lift Veracyte Inc.Market Volume Summary & Consistent Return Investment Signals - newser.com
Aug Summary: Is Ondas Holdings Inc forming a bullish divergenceEarnings Risk Report & Verified Technical Trade Signals - khodrobank.com
AQR Capital Management LLC Sells 34,410 Shares of Veracyte, Inc. $VCYT - MarketBeat
RSI Check: Is Veracyte Inc. a turnaround storyJuly 2025 Trade Ideas & Risk Controlled Daily Trade Plans - khodrobank.com
Is Veracyte Incs ROIC above industry average2025 Earnings Impact & Stepwise Trade Signal Guides - خودرو بانک
Exit strategy if you’re trapped in Veracyte Inc.Portfolio Return Summary & Safe Entry Momentum Tips - newser.com
Day Trade: Should I buy SPYU stock nowNew Guidance & Consistent Growth Stock Picks - خودرو بانک
Great Lakes Advisors LLC Sells 21,107 Shares of Veracyte, Inc. $VCYT - MarketBeat
Growth Report: Can Traeger Inc disrupt its industryTrade Performance Summary & Low Drawdown Trading Strategies - خودرو بانک
MACD Signal: Is Veracyte Inc a strong candidate for buy and holdMarket Trend Report & Intraday High Probability Alerts - خودرو بانک
Aug Patterns: What are the future prospects of Veracyte IncWeekly Gains Summary & Verified Momentum Watchlists - خودرو بانک
Whale Trades: Can Peoples Financial Services Corp. ride the EV wave2025 Retail Activity & Smart Allocation Stock Tips - خودرو بانک
Does Veracyte Inc. fit your quant trading modelMarket Volume Report & Risk Adjusted Swing Trade Ideas - newser.com
AQR Capital Management LLC Lowers Stock Position in Veracyte, Inc. $VCYT - Defense World
Veracyte (NASDAQ:VCYT) CEO Marc Stapley Sells 7,667 Shares - MarketBeat
Is Veracyte Inc. still worth holding after the dip2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Can trapped investors hope for a rebound in Veracyte Inc.Trade Entry Summary & Low Risk Entry Point Tips - Newser
Will Veracyte Inc. stock go up soonQuarterly Trade Summary & High Yield Stock Recommendations - Newser
Real time scanner hits for Veracyte Inc. explainedEntry Point & Low Risk Entry Point Tips - Newser
Tools to monitor Veracyte Inc. recovery probabilityJuly 2025 Trends & Risk Managed Investment Signals - Newser
Price momentum metrics for Veracyte Inc. explainedQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Will earnings trigger a reversal in Veracyte Inc.July 2025 WrapUp & Free Daily Entry Point Trade Alerts - Newser
Bridgeway Capital Management LLC Sells 41,300 Shares of Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. $VCYT Shares Purchased by Parkman Healthcare Partners LLC - MarketBeat
Veracyte (VCYT) Valuation in Focus as Groundbreaking Prostate Cancer Study Drives Clinical Adoption and Pipeline Progress - Sahm
Veracyte at Morgan Stanley Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa
Transcript : Veracyte, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 04 - MarketScreener
Veracyte at Morgan Stanley Conference: Strategic Growth and Innovation - Investing.com India
Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting - Business Wire
Veracyte CEO Stapley sells $233k in shares By Investing.com - Investing.com South Africa
Veracyte CEO Stapley sells $233k in shares - Investing.com India
Can Veracyte Inc. expand into new marketsWeekly Stock Report & Low Drawdown Momentum Trade Ideas - beatles.ru
Veracyte Inc (VCYT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.20%
자본화:
|
볼륨(24시간):